These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35806204)

  • 1. miR-29c Increases Protein Synthesis in Skeletal Muscle Independently of AKT/mTOR.
    Alves PKN; Cruz A; Silva WJ; Labeit S; Moriscot AS
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myostatin signaling regulates Akt activity via the regulation of miR-486 expression.
    Hitachi K; Nakatani M; Tsuchida K
    Int J Biochem Cell Biol; 2014 Feb; 47():93-103. PubMed ID: 24342526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheb, an activator of target of rapamycin, in the blackback land crab, Gecarcinus lateralis: cloning and effects of molting and unweighting on expression in skeletal muscle.
    MacLea KS; Abuhagr AM; Pitts NL; Covi JA; Bader BD; Chang ES; Mykles DL
    J Exp Biol; 2012 Feb; 215(Pt 4):590-604. PubMed ID: 22279066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanidinoacetic Acid Regulates Myogenic Differentiation and Muscle Growth Through miR-133a-3p and miR-1a-3p Co-mediated Akt/mTOR/S6K Signaling Pathway.
    Wang Y; Ma J; Qiu W; Zhang J; Feng S; Zhou X; Wang X; Jin L; Long K; Liu L; Xiao W; Tang Q; Zhu L; Jiang Y; Li X; Li M
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
    Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Effects of Sonic Hedgehog Against Ischemia/Reperfusion Injury in Mouse Skeletal Muscle via AKT/mTOR/p70S6K Signaling.
    Zeng Q; Fu Q; Wang X; Zhao Y; Liu H; Li Z; Li F
    Cell Physiol Biochem; 2017; 43(5):1813-1828. PubMed ID: 29065414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle.
    Amirouche A; Durieux AC; Banzet S; Koulmann N; Bonnefoy R; Mouret C; Bigard X; Peinnequin A; Freyssenet D
    Endocrinology; 2009 Jan; 150(1):286-94. PubMed ID: 18801898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy.
    Shi JY; Chen C; Xu X; Lu Q
    Acta Physiol (Oxf); 2019 Oct; 227(2):e13323. PubMed ID: 31162869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-133a alleviates airway remodeling in asthtama through PI3K/AKT/mTOR signaling pathway by targeting IGF1R.
    Shao Y; Chong L; Lin P; Li H; Zhu L; Wu Q; Li C
    J Cell Physiol; 2019 Apr; 234(4):4068-4080. PubMed ID: 30146725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-199a-3p regulates C2C12 myoblast differentiation through IGF-1/AKT/mTOR signal pathway.
    Jia L; Li YF; Wu GF; Song ZY; Lu HZ; Song CC; Zhang QL; Zhu JY; Yang GS; Shi XE
    Int J Mol Sci; 2013 Dec; 15(1):296-308. PubMed ID: 24378853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4
    Chen S; Wang Y; Qin H; Lin J; Xie L; Chen S; Liang J; Xu J
    Lupus; 2019 Apr; 28(4):510-519. PubMed ID: 30760089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-29c improves skeletal muscle mass and function throughout myocyte proliferation and differentiation and by repressing atrophy-related genes.
    Silva WJ; Graça FA; Cruz A; Silvestre JG; Labeit S; Miyabara EH; Yan CYI; Wang DZ; Moriscot AS
    Acta Physiol (Oxf); 2019 Aug; 226(4):e13278. PubMed ID: 30943315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
    Liu S; Zhang Y; Huang C; Lin S
    J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-145 alleviates Hcy-induced VSMC proliferation, migration, and phenotypic switch through repression of the PI3K/Akt/mTOR pathway.
    Zhang M; Li F; Wang X; Gong J; Xian Y; Wang G; Zheng Z; Shang C; Wang B; He Y; Wang W; Lin R
    Histochem Cell Biol; 2020 May; 153(5):357-366. PubMed ID: 32124010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-432 targeting E2F3 and P55PIK inhibits myogenesis through PI3K/AKT/mTOR signaling pathway.
    Ma M; Wang X; Chen X; Cai R; Chen F; Dong W; Yang G; Pang W
    RNA Biol; 2017 Mar; 14(3):347-360. PubMed ID: 28085550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanisms of skeletal muscle hypertrophy].
    Astratenkova IV; Rogozkin VA
    Ross Fiziol Zh Im I M Sechenova; 2014 Jun; 100(6):649-69. PubMed ID: 25665392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
    Teng P; Jiao Y; Hao M; Tang X
    J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer.
    Wu K; Hu Y; Yan K; Qi Y; Zhang C; Zhu D; Liu D; Zhao S
    J Cell Physiol; 2020 Feb; 235(2):1247-1258. PubMed ID: 31267531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.